文献速递乳腺MRUS

乳腺MRI可疑病灶二次超声引导下空芯针活检后置入标记夹MRI的价值

Post-clip placement MRI following second-look US-guided core biopsy for suspicious lesions identified on breast MRI.
PubMed 文献 · Eur Radiol · 2017-07-07

回顾性分析2014—2016年31例女性34个乳腺MRI可疑病灶,其中二次超声可显示的26例29个病灶行超声引导下空芯针活检并置入标记夹后复查MRI,技术成功率96.6%(28/29),肿块型成功率100%(28/28),非肿块型强化成功率83.3%(5/6),1例失败为良性1.1 cm非肿块型强化。

要点

  • 超声引导下活检后置入标记夹复查MRI可确认MRI可疑病灶是否被充分取材,技术成功率96.6%(28/29)。
  • 肿块型病灶技术成功率100%(28/28),非肿块型强化为83.3%(5/6)。
  • 唯一技术失败病例为良性、1.1 cm的非肿块型强化病灶。

核心结论

  • 超声引导下活检后置入标记夹复查MRI有助于确认MRI发现病灶的充分取材,作者认为该方法可能成为超声可见病灶替代MRI引导下活检的选择。

研究设计与样本

  • 2014—2016年连续纳入31例女性34个既往乳腺X线和超声未显示、由MRI检出的可疑病灶;二次超声可显示的26例29个病灶(平均大小1.5 cm,范围0.5—5.8 cm)行超声引导下空芯针活检、置入标记夹并复查MRI,二次超声未显示的5例5个病灶行MRI引导下活检;描述技术成功率和病灶特征。

诊断标准与关键数值

  • 技术成功率定义为超声引导下活检后置入标记夹复查MRI确认充分取材,总体为96.6%(28/29),肿块型为100%(28/28),非肿块型强化为83.3%(5/6)。

临床应用与阅片要点

  • 对乳腺MRI检出而乳腺X线和超声未显示、二次超声可定位的可疑病灶,可行超声引导下活检并置入标记夹后复查MRI以确认充分取材。
  • 非肿块型强化病灶的技术成功率(83.3%,5/6)低于肿块型(100%,28/28),阅片时应关注标记夹位置与病灶的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate whether the post-clip placement MRI following second-look ultrasound (US)-guided core biopsy is useful to confirm the adequate sampling of suspicious lesions identified on breast MRI.

METHODS: Between 2014 and 2016, 31 consecutive women with 34 suspicious lesions that had not been identified on previous mammography or US were detected using MRI. Among them, 26 women with 29 lesions (mean size 1.5 cm, range 0.5-5.8 cm) found by second-look US underwent US-guided biopsy, subsequent clip insertion and post-clip placement MRI. Five women with five lesions that were not found by second-look US underwent MRI-guided biopsy. The technical success rate and lesion characteristics were described.

RESULTS: The technical success rate was 96.6% (28/29). One failure case was a benign, 1.1-cm non-mass enhancement. Of the 28 success cases, 23 (82.1%) were masses and 5 (17.9%) were non-mass enhancements; 17 (60.7%) were benign, 4 (14.3%) were high-risk and 7 (25.0%) were malignant lesions. The technical success rate was 100% (28/28) for masses and 83.3% (5/6) for non-mass enhancements.

CONCLUSIONS: Post-clip placement MRI following US-guided biopsy is useful in confirming the adequate sampling of lesions identified on MRI. This method could be an alternative to MRI-guided biopsy for lesions visible on US.

KEY POINTS: • Post-clip MRI is useful for confirming adequate sampling of US-guided biopsy. • Post-clip MRI following US-guided biopsy revealed a 96.6 % technical success rate. • One technical failure case was a benign, 1.1-cm non-mass enhancement. • The technical success rate of US-guided biopsy for non-mass enhancements was 83.3 %.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Song SE, Cho N, Han W, et al. Post-clip placement MRI following second-look US-guided core biopsy for suspicious lesions identified on breast MRI. Eur Radiol. 2017. PMID: 28687909. doi:10.1007/s00330-017-4924-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。